Intuitive (NASDAQ: ISRG) stock (the robotic surgery company formerly known as "Intuitive Surgical") tumbled 5.8% through 11 a ...

ISRG posts strong preliminary Q4 and full-year 2025 revenue growth, but shares dip as investors weigh procedure trends, ...

Intuitive Surgical stock tumbled Wednesday after the robotic surgery giant issued a lackluster view for 2026 procedure growth ...

CEO Dave Rosa said a strong rollout for the da Vinci 5 surgical robot in 2025 exceeded expectations, with the system driving ...

Over 3 million procedures were performed globally on Intuitive daVinci systems last year, accounting for an 18% increase.

At the 2026 JP Morgan Healthcare event, Intuitive Surgical outlined how its robotic surgical systems continued to grow ...

At the end of the third quarter of 2025, Intuitive Surgical had placed 10,763 of its da Vinci surgical robot systems into ...

"Marshall’s rich experience strengthens our board as we move into our next phase of growth," CEO Maggie Nixon said.

Intuitive Surgical Q4 2025 revenue rose 19% y/y; 2026 procedure guidance disappointed, but da Vinci 5 strength supports Buy—read now.

Intuitive Surgical (NASDAQ: ISRG) has rewarded long-term investors by climbing nearly 200% over the past five years. This is thanks to the company's leadership in a hot growth area: robotic surgery.

Intuitive Surgical is selling an increasing number of da Vinci surgical robots. The number of procedures performed with a da Vinci robot is rising rapidly. The flywheel of Intuitive Surgical's ...